The analysis based on TCGA datasheets and paired NSCLC patients before and after EGFR-TKI resistance described HGF, MET-amplification and EGFR-T790M to upregulate the PD-L1 expression. This evidence concerns the gene EGFR and non-small cell lung carcinoma.